Clinical Trials in Denver

Showing 13161-13180 of 15,604 trials

A Phase 2 Extension of Study GCS-100-CS-4003

NCT02333955

The primary objective of this study is to determine the safety and tolerability of extended dosing with a fixed dose of GCS-100 3 mg IV push in patients with Chronic Kidney Disease (CKD).

Chronic Kidney Disease

La Jolla Pharmaceutical CompanyStarted Jan 2015

Tempe, Arizona, United States • La Mesa, California, United States • Denver, Colorado, United States +2 more locations

COMPLETEDPhase 2< 1 mile

A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis

NCT00050778

This was a Phase II, randomized, open-label, rater-blinded, three-arm study comparing two different doses of alemtuzumab (Lemtrada™) and one dose of subcutaneous (SC) interferon beta-1a (Rebif®) in participants with early, active relapsing-remitting multiple sclerosis (MS) who had not been previously treated with MS therapies other than steroids. The study was conducted for an initial period of 3 years and a follow-up to 5 years or more.

Multiple Sclerosis, Relapsing-Remitting

Genzyme, a Sanofi Company334 participantsStarted Dec 2002

Scottsdale, Arizona, United States • Little Rock, Arkansas, United States • Berkeley, California, United States +46 more locations

A Phase 2 Extension of Study GCS-100-CS-4003

A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis

Find Trials by Condition in Denver

Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder

A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome

A Study to Evaluate the Efficacy and Safety of Intravenous Peramivir in Subjects With Uncomplicated Influenza.

Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy

Study to Evaluate the Effect of KB001-A on Time-to-Need for Antibiotic Treatment

Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer

Identification of a Plasma Proteomic Signature for Lung Cancer

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)

MM-111 in Combination With Herceptin in Patients With Advanced Her2 Amplified, Heregulin Positive Breast Cancer

A 4-week, Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of HS-25 in Adults With Primary Hypercholesterolemia

Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Skin Infections

Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer

Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma

RAMP 200 / RAMP Cardiovascular Tests at the Point-of-Care

A Study of DER 45-EV Gel to Treat Rosacea

Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease

Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients

E7389 in Treating Patients With Recurrent or Progressive Stage IIIB or Stage IV Non-Small Cell Lung Cancer